Lessons learned from 500 cases of lymphatic mapping for breast cancer

Annals of Surgery

Volumn 229, Issue 4, 1999, Pages 528-535

  Hill, Arnold D K ^a   Tran, Katherine N ^a   Akhurst, Tim ^a   Yeung, Henry ^a   Yeh, Samuel D J ^a   Rosen, Paul Peter ^a   Borgen, Patrick I ^a   Cody III, Hiram S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROSANILINE DYES;

EID: 0033503934     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199904000-00012     Document Type: Article

References (15)

1. Rosen PP, Groshen S, Saigo P, Kinne DW, Hellman S. A long-term follow-up study of survival in Stage I (T1N0M0) and Stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989; 7:355-366.
2. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-401.
3. Giuliano AK, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350.
4. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative nodes. Lancet 1997; 349:1864-1867.
5. Giuliano AE, Barth AM, Spivack B, Beitsch PD, Evans SW. Incidence and predictors of axillary metastases in T1 carcinoma of the breast. J Am Coll Surg 1996; 183:185-189.
6. Krag DN, Ashikaga T, Harlow SP, Weaver DL. Development of sentinel node targeting techniques in breast cancer patients. Breast Journal 1998; 4:67-74.
7. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276:1818-1822.
8. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identity sentinel lymph-node in breast cancer. Lancet 1997; 349:1668-1669.
9. O'Hea BJ, Hill ADK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: the initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186:423-427.
10. Turner RR, Ollila DW, Krasne DL, Giuliano A. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226:271-278.
11. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J 1997; 3:336-340.
12. Meijer S, Collet GJ, Pijpers HJ, Van Hattum L, Hoekstra OS. Less axillary dissection necessary due to sentinel node biopsy in patients with breast carcinoma. Nederlands Tijdschrift voor Geneeskunde 1996; 140:2239-2243.
13. Nieweg OE, Kapteijn BA, Peterse JL, Rutgers EJ, van Dongen JA, Kroon BB. Identification of the sentinel node in patients with breast carcinoma. Nederlands Tijdschrift voor Geneeskunde 1996; 140: 2235-2239.
14. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227:645-653.
15. McNeil C. Four large studies aim to resolve sentinel node debate. J Natl Cancer Inst 1998; 90:729.